Molecule Details
| InChIKey | MQIMZDXIAHJKQP-UHFFFAOYSA-N |
|---|---|
| Compound Name | Prinaberel |
| Canonical SMILES | C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.3 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB06832 |
|---|---|
| Drug Name | Prinaberel |
| CAS Number | 524684-52-4 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Prinaberel is an estrogen receptor beta agonist. |
Categories: Receptors, Estrogen, agonists
Cross-references: BindingDB: 50154055 CHEMBL450940 ChemSpider: 20125926 PDB: 041 PubChem:5388909 PubChem:99443303 Wikipedia: Prinaberel ZINC: ZINC000003817763
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P18505 | GABRB1 | Homo sapiens | Human | PF02931 PF02932 | 8.3 | pIC50 | TTD_MultiTarget |
| Q92731 | ESR2 | Homo sapiens | Human | PF12497 PF00104 PF00105 | 8.3 | IC50 | ChEMBL;BindingDB |
| Q96WX4 | erg6 | Pneumocystis carinii (strain B80) | Pathogen | PF08241 PF08498 | 8.3 | pIC50 | TTD_MultiTarget |